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Abstract Evidence by functional imaging studies sug-
gests the role of left dorsolateral prefrontal cortex (DLPFC)
in the inhibitory control of nociceptive transmission sys-
tem. Repetitive transcranial magnetic stimulation (rTMS)
is able to modulate pain response to capsaicin. In the
present study, we evaluated the effect of DLPFC activation
(through rTMS) on nociceptive control in a model of
capsaicin-induced pain. The study was performed on
healthy subjects that underwent capsaicin application on
right or left hand. Subjects judged the pain induced by
capsaicin through a 0–100 VAS scale before and after 5 Hz
rTMS over left and right DLPFC at 10 or 20 min after
capsaicin application in two separate groups (8 subjects
each). Left DLPFC-rTMS delivered either at 10 and
20 min after capsaicin application significantly decreased
spontaneous pain in both hands. Right DLPFC rTMS
showed no significant effect on pain measures. According
to these results, stimulation of left DLPFC seems able to
exert a bilateral control on pain system, supporting the
critical antinociceptive role of such area. This could open
new perspectives to non-invasive brain stimulation proto-
cols of alternative target area for pain treatment.
Keywords Capsaicin ! Pain ! Prefrontal cortex ! Magnetic
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Introduction
Chronic pain represents a relevant medical condition with
detrimental effects on life quality and socio-economical
state. Patients with chronic pain may not respond positively
to standard pharmacological therapies and may require
other alternative approaches to relieve symptoms. In 1991,
Tsubokawa et al. [1] reported efficacy of motor cortex
stimulation (MCS) by dural implanted electrodes for
treatment of chronic, central, drug-resistant neuropathic
pain on 12 patients. Since then, a consistent bulk of evi-
dence showed this approach as being effective for pain
control in several patients [2–4]. On the basis of MCS
results, the introduction of transcranial magnetic stimula-
tion (TMS) has increased the opportunities to easily and
painlessly perform effective human cortex stimulation.
Moreover, the use of repetitive stimulation (rTMS) is also
able to induce long-lasting plastic changes, whose effects
depend on the stimulation frequency used: increased or
decreased excitability following low or high-frequency
TMS, respectively [5]. Motor cortex rTMS for control of
pain was first applied by Migita et al. [6] that showed pain
reduction in two patients treated by low-frequency
(\0.2 Hz) rTMS. Since then, evidence of potential effect of
motor cortex rTMS on pain control has been reported on
patients [7–10] as well as on pain model in healthy subjects
[11–13]. The great majority of TMS studies [7–10] focused
on motor cortex and this site has been considered the
optimal area for control of neuropathic pain also by
the EFNS Guidelines on Neurostimulation Therapy [14].
The reasons why stimulation of motor cortex is effective
in the treatment of pain are not yet completely known. In
the study by Tamura et al. [12], a SPECT analysis under the
condition of 1 Hz rTMS of right motor cortex (M1),
demonstrated a significant relative rCBF decrease in the
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right medial prefrontal cortex (MPFC), and a significant
increase in the caudal part of the right anterior cingulate
cortex (ACC) both correlating with pain reduction [12].
This could mean that motor cortex stimulation could
indirectly act on pain through the deactivation of MPFC
and activation of ACC.
Neurosurgical observations and functional imaging
studies have identified a matrix of structures in the brain
‘‘pain matrix’’ that responds to noxious stimuli in which
authors identified a clear division of functions between
sensory-discriminative and affective responses [15]. Inter-
esting results on pain syndromes also came by stimulation
of dorsolateral prefrontal cortex (DLPFC). First indicated
as a valid stimulation area for the treatment of depressive
states [16, 17], recently the DLPFC has also been consid-
ered a potential target for nociceptive control [18].
Functional imaging studies [19, 20] showed that DLPFC
activation is temporally related to amelioration of pain
sensation in a model of acute pain induced by capsaicin.
Since then DLPFC rTMS has been found effective for
the treatment of pain conditions such as chronic migraine
[21] and fibromyalgia [22].
In agreement with these results, recent studies showed
that DLPFC stimulation can be effective in pain control
significantly increasing the threshold for thermal and pain
sensation in healthy subjects [23–25] and reducing clinical
symptoms and the need for analgesic drugs on postopera-
tive and neuropathic pain [26, 27]. Moreover, the role of
DLPFC on pain control has been recently investigated with
another non-invasive brain stimulation technique: trans-
cranial direct current stimulation (tDCS) in healthy sub-
jects [28] and in patients with fibromyalgia [29].
On such grounds, the aim of our study was to explore
the analgesic effect of DLPFC rTMS in healthy subjects,
using a model of acute pain induced by topical application
of capsaicin that is known to activate nociceptive primary
afferent C-fibers with minimal contributions from other
somatosensory modalities [30, 31].
Materials and methods
We explored the effects of left and right DLPFC rTMS
over pain induced by capsaicin in a group of healthy sub-
jects. Sixteen healthy, right handed, drug-free volunteers
participated in the study. All subjects were unaware of the
study aim and had never experienced magnetic stimulation
before. They all signed an informed consent and the study
was conducted according to the Declaration of Helsinki.
Application of capsaicin and pain measures
Capsaicin (Dolpyc Teopharma 3%) was applied over the
dorsal surface of the right or left hands on a square area of
2 9 2 cm (see Fig. 1). Subjects judged the pain induced by
capsaicin through a 0–100 point visuoanalogic scale (VAS)
during application of capsaicin every 10 min for 60 min
(till capsaicin removal).
Transcranial magnetic stimulation
rTMS was delivered through a water-cooled figure of eight
coil, powered by a Cadwell High Speed Magnetic Stimu-
lator. According to Pascual Leone et al. [17], DLPFC was
localized on the scalp 5-cm anterior to the hot spot for the
contralateral abductor pollicis brevis (APB) muscle. To
check the correspondence of the stimulated point on the
scalp with the targeted brain area (DLPFC), we performed
a 3D graphical elaboration of MRI scans to localize
DLPFC in seven subjects. Then, a virtual marker was
positioned and reached in the real subject’s head using the
Brainvoyager QX neuro-navigation system. In all subjects,
Fig. 1 Site of capsaicin
application and flow chart of the
experiment: times for pain
measurements and rTMS
delivering (10 and 20 min after
capsaicin application)
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the corresponding site on the scalp was found to be very
close or overlapping the point where rTMS was performed
(5 cm anterior to the hotspot for APB muscle).
Motor threshold (MT) was measured at the hotspot of
the right APB muscle as the minimum stimulus intensity
able to elicit a motor evoked potential (MEP) of at least
50 lV in 5 or more of 10 consecutive stimulations. High-
frequency (hf) rTMS at 5 Hz rate was delivered in sessions
consisting of 1,800 stimuli each, divided in 12 trains (150
stimuli, 30 s duration each), given at 90% MT intensity and
separated by 10-s pause. rTMS was delivered over left and
right DLPFC.
Experimental paradigm
All subjects (8 M/8F; mean age 32.9 ±7, range
28–48 years) underwent hf rTMS over left and right DLPFC
after capsaicin application on right and left hand. In eight of
them (Experiment 1A), rTMS was delivered at 10 min and
in the remaining eight (Experiment 1B) at 20 min after
capsaicin application. In each group, subjects underwent
six different experimental sessions (3 conditions: capsaicin
alone, capsaicin ? left and capsaicin ? right DLPFC rTMS
9 2 hands) with at least 48-h interval between the sessions.
In each session, pain measures were evaluated every 10 min
for 60 min after capsaicin application. The order of the
sessions was randomized across subjects.
Statistical analysis
Repeated measures analysis of variance (ANOVA) has
been used to compare measures of pain across all experi-
mental sessions with and without rTMS. For Experiment 1,
the following factors were taken into consideration: (1)
between subjects: time of application of rTMS (2 levels: 10
and 20 min); (2) within subjects: hand (2 levels: right and
left), condition (3 levels: capsaicin alone, capsaicin ? left
and capsaicin ? right DLPFC rTMS), time of detection of
pain measures (7 levels = baseline, 100, 200, 300, 400, 500,
600). Newman Keuls test was performed for post hoc
comparisons (see ‘‘Results’’ for details).
Results
rTMS was well tolerated, capsaicin application only caused
local rush and a light to moderate burning sensation.
ANOVA for repeated measures with: conditions (3
levels: capsaicin alone, capsaicin ? left and right DLPFC
rTMS), times (7 levels 0–60 min.), hand (2 levels right and
left) as within-subject factors and rTMS timing (2 levels
10, 20 min) as between-subject factors showed a signifi-
cant main effect for the factors times F(6,84) = 174,20;
p\ 0.0001; conditions F(2,28) = 9,11; p\ 0.0009; and
for the interaction conditions 9 times F(12,168) = 8,30;
p\ 0.00001. No significant main effects were observed
neither for hands nor for rTMS timing. Newman–Keuls
post hoc test showed that (1) in condition without rTMS
(capsaicin alone), spontaneous pain significantly increases
on both hands after 20 min of capsaicin application and
further increased up to 60 min (see Table 1 for p values);
(2) the left DLPFC rTMS induces a significant pain
reduction with respect to the capsaicin alone condition at
40, 50 and 60 min (p values are reported in Table 2) after
capsaicin application on both hands and regardless of
rTMS time delivering (10 or 20 min). No significant
changes in pain measures were observed after right DLPFC
rTMS on both hands (see Figs. 2a, b, 3a, b).
Discussion
The results of this study show that rTMS delivered at high
frequency over the left DLPF cortex is able to inhibit
Table 1 p values of post hoc comparisons of VAS values at different
times (20–60 min) after capsaicin application with respect to baseline
(time 0) in condition without rTMS in the two groups
Minutes Right hand Left hand
100 rTMS 200 rTMS 100 rTMS 200 rTMS
20 \0.05 \0.01 \0.05 \0.05
30 \0.001 \0.0001 \0.0001 \0.01
40 \0.0001 \0.0001 \0.0001 \0.0001
50 \0.001 \0.0001 \0.0001 \0.0001
60 \0.0001 \0.0001 \0.0001 \0.0001
Table 2 p values of post hoc comparisons of VAS changes after 100
and 200 rTMS over left DLPFC at 40, 50 and 60 min after capsaicin
application, with respect to corresponding VAS values in capsaicin
alone condition and after 100 and 200 rTMS over right DLPFC
Right hand Left hand
Capsaicin alone
versus L-DLPFC
rTMS
R- versus
L-DLPFC
rTMS
Capsaicin alone
versus L-DLPFC
rTMS
R- versus
L-DLPFC
rTMS
100 rTMS (min)
40 \0.05 \0.05 \0.01 \0.05
50 \0.01 \0.05 \0.01 \0.05
60 \0.0001 \0.0001 \0.0001 \0.0001
200 rTMS (min)
40 \0.05 \0.001 \0.05 \0.05
50 \0.05 \0.05 \0.05 \0.01
60 \0.0001 \0.0001 \0.0001 \0.001
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responses to capsaicin-induced pain in healthy subjects.
Left DLPFC stimulation showed to exert antinociceptive
effects on both right and left hands. The effect seemed to
be specific because high-frequency rTMS of the contra-
lateral homologous cortical region (right DLPFC) was
completely ineffective on pain measures. To our knowl-
edge, this is the first evidence that hf rTMS given 10 or
20 min after capsaicin application on left DLPFC induces a
significant bilateral anti-nociceptive effect on capsaicin
pain model in healthy subjects.
The majority of the reports on modulation of pain neural
network have principally targeted motor cortex [7–13].
Recently, however, other cortical areas and in particular
DLPFC stimulation showed significant effect on pain
control [19–28]. Indeed, DLPFC appears to be a potential
candidate region to modulate the experience of pain given
that it is a critical structure for working memory and
attention functions [32, 33]. The relevance of DLPFC in
pain modulation and control has been particularly raised
among others by Lorenz et al. [19, 20]. They claimed that
this cortical area may have a ‘‘top–down’’ mode of inhi-
bition of neuronal coupling along the ascending midbrain–
thalamic–cingulate pathway through descending fibers
from the prefrontal cortex. Recently, this hypothesis
received experimental support by MRI studies of neural
connection with the technique of diffuse tensor imaging
that revealed anatomical connections between prefrontal
cortices and brainstem structures known for their role in
pain modulation like periaqueductal gray and nucleus
cuneiformis [34].
In agreement with our results, the role of left prefrontal
cortex activation in pain control has been recently reported
by Borckardt et al. showed that antinociceptive ability of hf
rTMS on this area in healthy subjects [23] and in patients
Fig. 2 Effects of left and right DLPFC rTMS (delivered at 10 min
after capsaicin application) on pain: changes in VAS values
(mean ± SE) across different times [baseline (0) to 60 min] in
conditions without and with rTMS with capsaicin over the right
(a) and left hand (b); asterisk indicates significant differences
(p\ 0.05) in L-DLPFC rTMS with respect to analog time points of
the other conditions
Fig. 3 Effects of left and right DLPFC rTMS (delivered at 20 min
after capsaicin application) on pain: changes in VAS values
(mean ± SE) across different times [baseline (0) to 60 min] in
conditions without and with rTMS with capsaicin over the right
(a) and left hand (b); asterisk indicates significant differences
(p\ 0.05) in L-DLPFC rTMS with respect to analog time points of
the other conditions
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with post-operative [26] and neuropathic pain [27]. The
antinociceptive effects of left DLPFC were also showed by
tDCS technique through stimulation of this area with
anodal activating currents in healthy subjects [28].
These papers, however, explored pain reduction only on
the body area contralateral to the brain area stimulated
(somatotopic), and are only partly comparable with our
results as they did not evaluate potential bilateral effects of
the brain stimulation performed. Only two studies, those by
Graff-Guerrero et al. [24] and by Nahmias et al. [25], have
till now explored this topic performing bilateral evaluation
of antinociceptive effects of cortical (M1 and DLPFC area)
stimulation. Graff-Guerrero et al. [24] investigated the
effect of right and left DLPFC rTMS on pain induced by
cold pressor test in healthy subjects, and found a bilateral
antinociceptive effect of low-frequency right DLPFC
stimulation on both hands. This could seem in contrast with
our results, as we used hf rTMS that is known to have
activatory effects and found antinociceptive effects by left
DLPFC. However, it could be argued, according to the
theory of interhemispheric rivalry, that following depres-
sion of the right side, an indirect activation of the opposite
left side DLPFC occurred (through removal of transcallosal
interhemispheric inhibition) in a way similar to what we
tried to induce by directly performing hf rTMS over left
DLPFC.
This also appears in agreement with the results reported
by Tamura et al. [12] in a study that explored antinoceptive
effect of rTMS on capsaicin-induced pain. These authors
were able to induce pain reduction by 1 Hz rTMS over
right M1 and documented through SPECT imaging a
decreased activation of the right DLPFC together with an
increased activation of contralateral motor and prefrontal
cortices. Moreover, as we showed in a recent paper, left
DLPFC activation was also able to exert control over motor
cortical excitability restoring intracortical inhibition that
had been reduced by capsaicin application [35].
With regards to the relationship between motor and
prefrontal cortices in pain modulation, Graff-Guerrero
et al. [24] compared the effect of DLPFC and M1 stimu-
lation and found that differently from DLPFC, motor cor-
tex is able to exert only contralateral control on pain. This
would point towards a more general role for DLPFC in
pain control in agreement with the top-down model pro-
posed by Lorenz et al. [19, 20]. This view, however, has
been recently challenged by the results of Nahmias et al.
[25] that found bilateral analgesic effects not only by DLPFC,
but also by M1 stimulation, performing high-frequency
instead of slow rTMS on the right DLPFC in healthy
subjects. These differences do not appear easy to explain:
in our opinion, a critical role may have been played by the
different methodological approaches, as it is known that
varied effects of DLPFC rTMS on acute pain may be
influenced by the type of experimentally induced pain.
Indeed, pain elicited by capsaicin and mediated by acti-
vation of C-fiber pathways has been shown to be reduced
by slow rTMS of right motor cortex [12], whereas the same
rTMS procedure has been shown to increase the acute
laser-implemented pain primarily involving A delta fibers
[13]. Under this respect, the results by Nahmias et al. [25]
could be explained by the different pain induction tech-
nique (thermal stimulation) likely involving more A delta
than C-fibers activation. Indeed, if we speculate that right
DLPFC is involved in control of pain arising by A delta
fibers activation, then activation by fast rTMS of this area
could reduce pain [25], while inhibition through slow
stimulation would increase it [13]. Unfortunately, Nahmias
et al. [25] performed only stimulation of right DLPFC, so
we do not know the potential antinociceptive effects of left
side DLPFC rTMS in their experimental pain paradigms.
However, inference about this issue could be given by
Borckhardt et al. [23] that used similar nociceptive
induction as Nahmias, but performed activation of the
opposite (left) DLPFC obtaining similar antinociceptive
effect. Therefore, it should be argued that at least for this
pain type, both left and right DLPFC could exert effective
analgesic effects. With regards to this point could be
interesting the observation by a recent rTMS study (even if
not strictly related to pain control) that both left and right
DLPFC are needed to induce an effective placebo analgesia
phenomenon [36].
Other important methodological aspects that could
affect the response to rTMS could concern the intensity and
duration of pain stimulation and its ability to activate the
descending nociceptive inhibitory control system (DNIC).
Nahmias et al. [25] were not able to induce DNIC activity,
as they recorded no changes in RIII (a measure of DNIC
activation); whereas cold pressor test [24] that give a more
intense pain, and capsaicin that induce continuous painful
stimulation, are more likely to activate DNIC [20, 37]. In
this regard, DNIC has also been shown to be modulable by
cortical structures such as DLPFC, which is involved in
pain control and in phenomena of pain expectation and
placebo [36, 38, 39].
Taken together, these data would suggest that antinoci-
ceptive DLPFC activation would involve more right or left
side depending on the different qualitative and quantitative
aspects of pain. However, several controversial aspects
remain and more evidence is needed concerning the effects
of right versus left DLPFC and of slow versus fast rTMS in
different experimental pain conditions, to evaluate the
existence and role of DLPFC interhemispheric differenti-
ation and/or interaction and the relationship with motor
cortex in pain processing and control.
As to the timing of magnetic stimulation, in our study,
we obtained significant antinociceptive effect by giving
J Headache Pain (2011) 12:185–191 189
123
rTMS at both 10 and 20 min after capsaicin application.
This timing was chosen because subjects reported pain at
10 min after capsaicin application and the increased VAS
values became significant at 20 min. At both rTMS
delivering times, the antinociceptive effect began just after
magnetic stimulation and remained stable across the
observation period (60 min). In our opinion, this could
have different explanations: it could be due to the lasting
effects of rTMS or to the fact that 10–20 min after cap-
saicin application could represent a critical time window
for activation of antinociceptive mechanisms. The fact that
significant antinociceptive effect begins after 40 min from
capsaicin application for both 100- and 200-rTMS is not
easy to explain. It could be that 40 min represents a critical
time point (as concerns magnitude of VAS score differ-
ence) to observe a statistical significance of 100- and 200-
rTMS effects with respect to capsaicin alone condition.
In conclusion, our findings support the role of DLPFC
on nociceptive modulation and control and point towards
the opportunity to further investigate the activation of left
and right DLPFC in pain processing, with the final aim to
optimize strategies for potential therapeutical application in
pain conditions.
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